Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application of CD-001, entering a Phase I first-in-human trial. CD-001, the ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic disorders and cancer due to ...

Innovent Biologics has made the case that its checkpoint inhibitor-cytokine fusion protein has a future in colorectal cancer.

All complex life on Earth, including plants and animals, are made up of eukaryotic cells, which are more sophisticated than ...

Cells were divided into six groups ... And then the PCR products were cloned into p3XFLAG-CMV-14 at BamHI and EcoRV sites. The respective FLAG-fusion fragments were then cloned into pLVX-IRES-puro ...

The novel ROS1 inhibitor zidesamtinib demonstrated promising early activity in heavily pretreated patients with advanced ROS1 ...

However, the study suggests this is not always the case. Cancer cells can merge (through cell fusion) or acquire traits from other cells. This could make the growth pattern of cancers more complex, ...

From gigantic planets and stars to tiny cells, all matter in our universe is made of building ... Nuclear energy can be produced by two processes – nuclear fission and nuclear fusion. Nuclear fission ...

In a nutshell: An unlikely contestant has emerged in the race toward cracking the fusion code, which has seen the biggest labs and richest billionaires pouring billions into various projects ...

Their new research is the first to comprehensively investigate the elevated expression of a gene called ZIC2 in ovarian cancer cells, finding that it is associated with poor survival rates of ...

Rad Slavov is the Editor-in-Chief at PhoneArena. He joined the media in 2008, right on the cusp of the modern smartphone revolution. Through time and perseverance, he amassed a great deal of knowledge ...